Intimation of Schedule of the Investors/Analysts Conference Call (group meet) for un-audited financial results of Q2 FY 2026-27

Ref: Akums/Exchange/2026-27/56 October 28, 2026 To, To, The Listing Department The Listing Department National Stock Exchange of India Ltd BSE Limited Exchange Plaza, C-1, Block G, 25th Floor, New Trading Ring, Bandra Kurla Complex, Rotunda Building, Phiroze Jeejeebhoy Bandra (E), Mumbai – 400 051 Towers, Dalal Street, Mumbai – 400 001 Symbol: AKUMS Scrip Code: 544222 Sub: Intimation of Schedule of the Investors/Analysts Conference Call (group meet) for un- audited financial results of Q2 FY 2026-27 Respected Sir/Ma’am, This is to inform you that pursuant to regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Akums Drugs and Pharmaceuticals Limited will be hosting below scheduled investor/analysts conference call (group meet): S. No. Particulars of Date of Meeting Type of Location / Mode Meet Meet of Meeting 1 Earning/Quarterly November 03, 2026 Group meet Virtual Calls Starts at 12:00 PM (IST) Please find enclosed Dial-in details for the same. Further, no unpublished price sensitive information pertaining to the Company will be shared during the Investors/Analysts Conference Call. Please note that the above schedule may subject to change due to exigencies on the part of Investors/analysts or Company. A copy of this disclosure is being updated on website of the Company at www.akums.in This is for your information and records. For Akums Drugs and Pharmaceuticals Limited Dharamvir Malik Company Secretary & Compliance Officer Encl: As above Akums Drugs & Pharmaceuticals Ltd. Q2 FY27 EARNINGS CALL November 03, 2026 12:00 pm (IST) Company Representatives Conference Call Details Mr. Sanjeev Jain – Managing Director Date Time November 03, 2026 12:00 pm (IST) Mr. Sandeep Jain – Managing Director Mr. Sumeet Sood – Chief Financial Officer Please join the conference via Diamond Pass to avoid wait time. Please click here to register. Mr. Sahil Maheshwari – Head Strategy Primary Access Numbers International Toll Free Numbers +91 22 6280 1488 Singapore: 800 101 2045 USA: 1 866 746 2133 +91 22 7115 8869 Hong Kong: 800 964 448 UK: 0 808 101 1573 We request you to dial in a few minutes prior to the scheduled time.